RecallRadar

FDA Drug recall D-1234-2020

Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc

On 2020-04-22 the FDA classified a Class II recall of Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc by Aurobindo Pharma Usa, citing CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1234-2020
ClassificationClass II
Statusterminated
Initiated2020-03-18
Published2020-04-22
Last updated2026-09-13 11:52 UTC
CompanyAurobindo Pharma Usa
DistributionUS

Product

Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90

Reason

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Identifiers

ndc65862-050-30
ndc65862-050-45
ndc65862-050-90
ndc65862-050-01
ndc65862-050-00
ndc65862-050-99
ndc65862-050-26
ndc65862-051-30
ndc65862-051-45
ndc65862-051-90
ndc65862-051-01
ndc65862-051-00
ndc65862-051-99
ndc65862-051-26
ndc65862-052-30
ndc65862-052-45
ndc65862-052-90
ndc65862-052-01
ndc65862-052-00
ndc65862-052-99
ndc65862-052-26
ndc65862-053-30
ndc65862-053-45
ndc65862-053-90
ndc65862-053-01
ndc65862-053-00
ndc65862-053-99
ndc65862-053-22
ndc65862-054-30
ndc65862-054-45
ndc65862-054-90
ndc65862-054-00
ndc65862-054-99
ndc65862-054-39
code_infoLot #: 05319004A1, Exp. Date 03/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1234-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.